Skip to search.
 TSX Down 0.94% TSX Ventures Down 3.46%

Osiris Therapeutics, Inc. (OSIR)

-NasdaqGM
4.97 Aug 24, 4:00PM EDT
Prev Close:4.97
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:8.00
Beta:-0.148277
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:3.55 - 20.42
Volume:0
Avg Vol (3m):86,422
Market Cap:171.23M
P/E (ttm):118.33
EPS (ttm):0.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OSIR 0.00%171.23M
UCBJY15.52B
BIIB67.78B
ABT63.46B

Key Statistics

Forward P/E (1 yr):38.23
P/S (ttm):1.98
Ex-Dividend Date:14-Oct-15

Analysts

Annual EPS Est (Dec-15) :0.08
Quarterly EPS Est (Dec-15) :0.06
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chroni... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback